Skip to main content

Table 8 List of rare diseases as identified by Orphadata and in AACT but with unknown class of prevalence

From: Does the low prevalence affect the sample size of interventional clinical trials of rare diseases? An analysis of data from the aggregate analysis of clinicaltrials.gov

Diseases/conditions

No. of trials, m

(%)

Allergic bronchopulmonary aspergillosis

1

(2.70)

Amyloidosis

5

(13.51)

Arachnoiditis

1

(2.70)

Aspergillosis

5

(13.51)

Cutaneous mastocytosis

1

(2.70)

Erdheim-Chester disease

2

(5.40)

Fibrous dysplasia of bone

2

(5.40)

Germ cell tumor

3

(8.10)

Heparin-induced thrombocytopenia

1

(2.70)

Hereditary pulmonary alveolar proteinosis

1

(2.70)

Idiopathic nephrotic syndrome

1

(2.70)

Intrahepatic cholestasis of pregnancy

1

(2.70)

Kawasaki disease

1

(2.70)

Ligneous conjunctivitis

1

(2.70)

Loiasis

1

(2.70)

POEMS syndrome

2

(5.40)

Precocious puberty

3

(8.10)

Solitary fibrous tumor

1

(2.70)

Synovial sarcoma

1

(2.70)

Thymic carcinoma

2

(5.40)

Zygomycosis

1

(2.70)